Woodline Partners LP Baxter International Inc Transaction History

Woodline Partners LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$37.58 - $52.57 $90.2 Million - $126 Million	2,401,172 Added 881.47%	2,673,578 $108 Million
Q4 2022 Feb 14, 2023	SELL	$49.7 - $57.71 $5.85 Million - $6.79 Million	-117,667 Reduced 30.17%	272,406 $13.9 Million
Q3 2022 Nov 14, 2022	BUY	$53.86 - $66.8 $3,070 - $3,807	57 Added 0.01%	390,073 $21 Million
Q2 2022 Aug 15, 2022	SELL	$63.83 - $80.0 $9.98 Million - $12.5 Million	-156,329 Reduced 28.61%	390,016 $25.1 Million
Q1 2022 May 16, 2022	BUY	$76.85 - $89.45 $2.3 Million - $2.67 Million	29,894 Added 5.79%	546,345 $42.4 Million
Q4 2021 Feb 14, 2022	SELL	$74.57 - $87.19 $1.85 Million - $2.16 Million	-24,773 Reduced 4.58%	516,451 $44.3 Million
Q3 2021 Nov 15, 2021	BUY	$73.77 - $83.61 $39.9 Million - $45.3 Million	541,224 New	541,224 $43.5 Million
Q2 2020 Aug 14, 2020	SELL	$78.66 - $94.14 $19.8 Million - $23.7 Million	-252,032 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$71.57 - $93.3 $12.1 Million - $15.7 Million	168,804 Added 202.82%	252,032 $20.5 Million
Q4 2019 Feb 14, 2020	BUY	$76.7 - $88.45 $6.38 Million - $7.36 Million	83,228 New	83,228 $6.96 Million

981

446M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $19.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.